Home
Acrotech BioPharma

Acrotech BioPharma Market Share Analysis for August 2026

Industry: N/A

Domainacrotechbiopharma.com

Year Founded2018

Employees51 - 200

Annual Revenue$500M - $1B

Acrotech BioPharma

Acrotech BioPharma (including company regionals)

acrotechbiopharma.com

See more website traffic and engagement information

Acrotech BioPharma Revenue up to August 2026 is 500M - 1B

revenue generated by Acrotech BioPharma top domains

Acrotech BioPharma top domains revenue over 3 years

Revenue for Acrotech BioPharma top domains

acrotechbiopharma.com500M - 1B

See more with Sales Intelligence

Total visits to Acrotech BioPharma's top domains

Understand Acrotech BioPharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

acrotechbiopharma.com2.2K

See more with Sales Intelligence

Avg. visit duration in Acrotech BioPharma's top domains

Analyze Acrotech BioPharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

acrotechbiopharma.com00:00:36

See more with Sales Intelligence

Avg. pageviews on Acrotech BioPharma's top domains

See how Acrotech BioPharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

acrotechbiopharma.com1.77

See more with Sales Intelligence

Acrotech BioPharma top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Acrotech BioPharma

These are the website technologies, by industry, used by Acrotech BioPharma top domains

Widget (6)

Twemoji

Email Services (3)

Microsoft Exchange Online

Mobile (2)

Meta Viewport

Recruitment (2)

iCIMS

More Technologies

8

See all

News & Signals from Acrotech BioPharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAcrotech Biopharma, LLC partners with Otsuka.Acrotech Biopharma Inc., in collaboration with Otsuka Pharmaceutical Co., Ltd., announced that the FDA approved Adquey (difamilast 1%) ointment for the topical treatment of mild-to-moderate atopic dermatitis in adults and pediatric patients aged 2 years and older.

NewsAcrotech Biopharma, LLC partners with U.S. Food and Drug Administration.After some major delays, Acrotech has finally formed a confirmatory trial agreement with the FDA to test the two drugs in a phase 3 trial in the front-line setting.